Repligen Corp. (RGEN)
124.95
-0.81
(-0.64%)
USD |
NASDAQ |
May 07, 12:18
Repligen SG&A Expense (TTM) : 219.25M for March 31, 2026
SG&A Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (TTM) Benchmarks
| Masimo Corp. | 386.60M |
| Orthofix Medical, Inc. | 421.35M |
| InfuSystem Holdings, Inc. | 67.46M |
| Tandem Diabetes Care, Inc. | 444.99M |
| 908 Devices, Inc. | 28.29M |